Knee Osteoarthritis and Its Impact

Overview of Knee Osteoarthritis

Knee osteoarthritis is a prevalent and debilitating condition affecting many North Americans. It is characterized by inflammation in the joint and often involves inflammation of the synovial membrane, known as synovitis. This condition impacts millions worldwide and ranks as a leading degenerative orthopedic disorder.

Symptoms and Progression

Patients with knee osteoarthritis typically experience pain, joint deterioration, and a decline in function due to progressive inflammation. This inflammation can also occur in the synovial cavities, further intensifying symptoms.

Treatment Approaches and Concerns

Corticosteroid Injections

To address inflammation, anti-inflammatory corticosteroids are theorized to be effective when injected into the joint, potentially slowing disease progression. However, these corticosteroids possess anti-anabolic properties that may compromise healthy cartilage over time. Current research has produced inconclusive results regarding the impact of corticosteroid injections on soft knee tissue.

Research Study Overview

A recent study published in JAMA, conducted by McAlindon and colleagues, explored the effects of intra-articular corticosteroid injections on pain and knee cartilage volume. The study involved 140 participants aged 45 and older diagnosed with knee osteoarthritis. Participants were divided into two groups: one receiving corticosteroid injections and the other receiving saline injections. Injections were administered every three months for two years, with knee evaluations conducted at each visit. More detailed assessments, including MRIs, were performed annually.

Study Results

The findings revealed that participants receiving corticosteroid injections experienced significantly greater cartilage volume loss compared to those receiving saline injections, with no notable difference in pain levels. This outcome contradicts a previous study that reported no adverse effects from corticosteroid injections, suggesting that differing measurement techniques may account for the discrepancy. McAlindon and colleagues utilized MRI to assess cartilage volume, offering greater detail than the radiography method employed in the previous study.

Long-Term Considerations

While neither group exhibited progression of osteoarthritis, the observed cartilage volume loss could potentially lead to further health issues over time. Additionally, there is speculation that saline injections might serve as a treatment option for knee osteoarthritis. However, the strong placebo effect associated with intra-articular injections complicates this notion, as no studies have incorporated sham injections, leaving this theory unproven.

Conclusion

In summary, the study indicates a significant loss of cartilage volume associated with intra-articular corticosteroid injections compared to saline injections. This cartilage loss may pose greater health risks in the future, suggesting that corticosteroid injections should not be considered a viable treatment option for patients suffering from knee osteoarthritis.

Written By: Wesley Tin, MBSc